MAY 2018: HEP HEADLINES

2 May 2018 Bridie Taylor

Viral hepatitis is making the headlines. Here’s the latest news from the field of viral hepatitis this month.

Founder of the World Hepatitis Alliance appointed as Executive Director of the Medicines Patent Pool

This month the Medicines Patent Pool (MPP) announced the appointment of Charles Gore as the new MPP Executive Director. Charles takes up the role after two decades

World Health Organization announces new hepatitis C recommendations

According to new evidence gathered for WHO’s upcoming hepatitis C treatment guidelines, access to a cure for hepatitis C is increasing, with simplified and more affordable treatments becoming more readily available. Major simplification and its delivery means global scale-up is now possible. WHO announced the new direction at the International Liver Congress where they also highlighted findings from their recent Progress report on access to hepatitis C treatment.

Innovative new approach to explaining hepatitis B to children

WHA member Hepatitis Victoria has launched a unique children’s book and animation Little Hep B Hero that aims to help families raise awareness about viral hepatitis, increase health literacy and break the silence. The book is available in English, Simplified Chinese and Vietnamese and can be ordered from Hepatitis Victoria’s website here.

Turkey launches viral hepatitis plan

The Government of Turkey committed to hepatitis elimination at the viral hepatitis elimination conference in Ankara, Turkey on 3 April.

Interactive webinar provides tips and tricks for marking World Hepatitis Day 2018

On 25 April we hosted our annual World Hepatitis Day webinar. The webinar provided an overview of the Find the Missing Millions campaign, tips and tricks on making an impact on World Hepatitis Day and inspiration for event and activities. If you were unable to attend, catch up on the discussions with the video recording and slide deck.

Read more in the latest edition of hepVoice, your monthly magazine from the World Hepatitis Alliance.